A scientist that undertook a subgroup analysis passed nearby a prison sentence in the US.
W. Scott Harkonen have been convinced of false dissemination and misleading statement for his interpretation by subgroup analysis of a clinical trial results. He is accused by the Feds of manipulating the data with a subgroup analysis such modifying the primary endpoint of the trial. The following dissemination of the results he obtained provoked a wide off label prescription of the drug tested in the trial. The consequences were inappropriate spending for Medicaid and Medicare. The cost of off label prescription for one patient-year was approximately $50,000. This cost is proportional to the severity of the sentence pronounced by the judge. Pharmalot reported this lawsuit in several posts, the last report being available here.